AUPH
Aurinia Pharmaceuticals Inc
NASDAQ · Biotechnology
$14.44
+0.18 (+1.26%)
Open$14.26
Previous Close$14.26
Day High$14.54
Day Low$14.20
52W High$16.54
52W Low$6.55
Volume—
Avg Volume956.4K
Market Cap1.90B
P/E Ratio24.46
EPS$0.56
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+181.4% upside
Current
$14.44
$14.44
Target
$40.64
$40.64
$34.07
$40.64 avg
$61.77
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 212.05M | 122.74M | 596.78M |
| Net Income | 5.18M | 2.70M | -161,211,616 |
| Profit Margin | 2.5% | 2.3% | -27.0% |
| EBITDA | 13.30M | 7.32M | -198,130,665 |
| Free Cash Flow | — | — | -93,265,267 |
| Rev Growth | +72.8% | +72.8% | +3.8% |
| Debt/Equity | 0.19 | 0.19 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |